TNFSF10 and central nervous system cancer: They have shown that its down-regulation potentiates the effects of glucose deprivation [20] and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [23] in glioma cells, and the inhibition of growth signaling in breast cancer cells [24].